MedTrace Logo

Tailored Bilio-Pancreatic Limb and HbA1c 10 Years Post Mini-Gastric Bypass

NCT04442698 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 130

Last updated 2020-06-22

No results posted yet for this study

Summary

Diabetes is now or soon will be a worldwide epidemic. Diabetes has impact on both healthcare costs in addition to the costs in human lives, suffering and disability. Treatment that lowers Hemoglobin A1c (HbA1c) improved outcomes. Studies have demonstrated that both general surgery and bariatric procedures may improve or reverse diabetes. In several studies the Billroth II reconstruction following gastrectomy was the most effective surgical technique in improving or reversing Diabetes. The purpose of this study is to analyze the outcomes of the Mini-Gastric Bypass-Original Technique (MGB-OT) version of the One Anastomosis Bypass (OAGB) to investigate the association of a "Tailored" Bilio-pancreatic Limb Length (BPLL) with the HbA1c changes.

Conditions

Interventions

PROCEDURE

Mini-Gastric Bypass Original Technique

Follow up of the Surgical procedure outcomes in diabetics. Procedure Mini-Gastric Bypass Original Technique

Sponsors & Collaborators

  • Kular Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-01-01
Primary Completion
2019-01-01
Completion
2020-01-01

Countries

  • India

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04442698 on ClinicalTrials.gov